Fed Circ. Urged To Invalidate Illumina Sequencing Patent
Intelligent Bio-Systems Inc. on Wednesday urged the Federal Circuit to overturn a Patent Trial and Appeal Board ruling affirming the validity of rival Illumina Cambridge Ltd.'s DNA sequencing patent, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article